Join JAX at Society for Neuroscience
(SfN) Annual Meeting - 2019

Learn more about how JAX is enabling you to unravel
the pathway of your neurobiological research, including
our comprehensive mouse model catalog, knowledgeable study
directors to help you define your readouts, and wide range of
preclinical efficacy studies.

Booth #525

Oct 19 - Oct 23 | Chicago, IL

Schedule a Meeting

Meet with a JAX representative at Booth #525

Click the button below to schedule a meeting with a JAX representative.

SCHEDULE A MEETING

RSVP for The Jackson Laboratory Breakthrough Breakfast

Join us for The Jackson Laboratory Breakthrough Breakfast

Learn about the partnership between research labs and biotech to develop new genetic treatments for rare, neurological diseases.

Click the button below to RSVP for this event.

Register Now

JAX Posters

Title Author(s) Session
210.09. Cross-species analyses identify Dlgap2 as a mediator of age-related cognitive decline and Alzheimer's disease S. M. NEUNER, L. DUMITRESCU, L. ANDERSON, D. M. GATTI, A. R. OUELLETTE, E. MAHONY, J. A. BUBIER, G. CHURCHILL, L. PETERS, H.-S. YANG, C. REITZ, B. KUNKLE, C. C. WHITE, P. L. DE JAGER, J. A. SCHNEIDER, D. A. BENNETT, E. J. CHESLER, T. J. HOHMAN, C. C. KACZOROWSKI; Poster: 210 - Alzheimer's Disease: Genetics
473.01. Lifespan magnetic resonance imaging of novel mouse models of Alzheimer's disease: Phenotyping and comparisons to healthy aging A. JULLIENNE, A. OBENAUS, J. LEE, J. I. SZU, E. J. BEHRINGER, M. AD CONSORTIUM Poster: 473 - Alzheimer's Disease and Other Dementias: Therapeutic Strategies II
473.03. Characterization and deep phenotyping of the 5xfAD mouse model by MODEL-AD
S. FORNER, M. AD CONSORTIUM Poster: 473 - Alzheimer's Disease and Other Dementias: Therapeutic Strategies II
473.07. Comparative transcriptome analysis of MODEL-AD mouse models G. BALDERRAMA-GUTIERREZ, A. MORTAZAVI, M. AD CONSORTIUM Poster: 473 - Alzheimer's Disease and Other Dementias: Therapeutic Strategies II
566.13. CHCHD10 a protein at the intersection of mitochondrial diseases and ALS-FTD H. KAWAMATA, C. J. ANDERSON, K. BREDVIK, S. M. MEADOWS, C. M. LUTZ, G. MANFREDI5 Poster: 566 - Neurodegeneration Mechanisms
591.11. Elevated dietary sucrose consumption induces AgRP neuronal circuit dysregulation and leptin resistance without altering body weight A. C. KORGAN, K. ABREU, K. GRAHAM, W. WEI, S. L. A. MARTIN, K. M. S. O'CONNELL; Poster: 591 - Food Intake and Energy Balance: Integration of Peripheral Signals
742.15. The Michael J. Fox Foundation’s efforts to understand the relationship between GBA1 and alpha-synuclein through the development and characterization of preclinical models B. CASEY, N. POLINSKI, T. N. MARTINEZ, S. W. CLARK, S. M. SMITH, R. C. SWITZER III, S. O. AHMAD, S. RAMBOZ, M. SASNER, M. T. HERBERTH, L. MENALLED, M. A. BAPTISTA, K. D. DAVE, M. FRASIER Poster: 742 - Alpha-Synuclein Models and Mechanisms II